Products for Research Use Only
RegisterLogin

Revumenib Citrate

CAT: 0013-GTR19241675-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19241675-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Revumenib (SNDX-5613) is a potent and selective small molecule inhibitor of the Menin-MLL interaction, used for researching MLL-rearranged leukemias such as ALL and AML. It has demonstrated activity in both in vitro cellular assays and in vivo xenograft models, supporting its investigation as a targeted therapeutic agent.
CAS Number
2761046-45-9
Smiles
C (CC (O) =O) (CC (O) =O) (C (O) =O) O.C (N1CCC2 (CN (C2) C=3C (OC4=C (C (N (C (C) C) CC) =O) C=C (F) C=C4) =CN=CN3) CC1) [C@@H]5CC[C@@H] (NS (CC) (=O) =O) CC5.O
Molecular Formula
C38H57FN6O12S
Molecular Weight
840.96
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19154219-01Revumenib
GTR19221848TRIMETHYL CITRATE
GTR19216839-01Piperazine citrate
GTR19209729-01Roblitinib citrate
GTR19205932-01Dacarbazine citrate
GTR19205416-01Methyllycaconitine citrate
GTR19199117-01Isoaminile citrate
GTR19243364-01Lead citrate
GTR19175459-01Diethylcarbamazine citrate
GTR19163623-01Mosapride Citrate

Alternative Products

CatalogName
T202855-01Revumenib Citrate
C8689-10Revumenib
S8996-5mgRevumenib (SNDX-5613)
C21534-1gSNDX-5613 (Revumenib)
A22526-2Revumenib (SNDX-5613) 2mg
A22526-25Revumenib (SNDX-5613) 25mg
A22526-1Revumenib (SNDX-5613) 1mg
A22526-10mM-DRevumenib (SNDX-5613) 10mM * 1mL in DMSO
MBS653895-01Citrate Synthase (Citrate Condensing Enzyme, Citrate Oxaloacetate Lyase)
290636-01Tofacitinib Citrate (CP-690550 Citrate)

Popular Products